🟢 Wave Life Sciences is trading 6.05% up in pre-market after 16.89% August 11 drop

Wave Life Sciences is trading at $5.35, up +6.05% in pre-market after rebounding from its 16.89% August 11 decline to $5.04.

• Management discussed WVE-007, WVE-006, and WVE-008 at the Bank of America SMID Cap Virtual Conference.
• The company is scheduled to present at the Canaccord Genuity Growth Conference on August 12.
• No confirmed new clinical, regulatory, or earnings catalyst directly explains the pre-market gain.